Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2025

Mar 18, 2025

29871_dirs_2025-03-18_b4a7b1fe-74f8-46e6-b204-ba8520698d7b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2025-03-15

Reporting Person: McCourt Timothy Francis (Sr MD Global Head Equity & FX)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-15 Common Stock Class A A 317 $258.68 Acquired 7592 Direct
2025-03-15 Common Stock Class A F 162 $258.68 Disposed 7430 Direct
2025-03-15 Common Stock Class A A 1134 $258.68 Acquired 8564 Direct
2025-03-15 Common Stock Class A F 579 $258.68 Disposed 7985 Direct
2025-03-15 Common Stock Class A F 96 $258.68 Disposed 7889 Direct

Footnotes

F1: For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.

F2: Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.

F3: For the PSAs granted in March 2022: Represents shares earned from a March 2022 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.

F4: Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2025.